View in EDS

mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent models.

Saved in:
Bibliographic Details
Title: mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent models.
Authors: Agrawal N; BioNTech SE, Mainz, Germany., Ates LS; BioNTech SE, Mainz, Germany. louis.ates@biontech.de., Schille SA; BioNTech SE, Mainz, Germany., Chaturvedi A; BioNTech SE, Mainz, Germany., Vogt J; BioNTech SE, Mainz, Germany., Vukovic N; BioNTech SE, Mainz, Germany., Dulberger CL; BioNTech US, Cambridge, MA, USA., Vogel AB; BioNTech SE, Mainz, Germany., Diekmann J; BioNTech SE, Mainz, Germany., Diken M; BioNTech SE, Mainz, Germany. mustafa.diken@biontech.de.; Translational Oncology at the University Medical Center of the Johannes Gutenberg-University Mainz (TRON), Mainz, Germany. mustafa.diken@biontech.de., Şahin U; BioNTech SE, Mainz, Germany.; Helmholtz Institute for Translational Oncology (HI-TRON), Mainz, Germany.
Source: Nature immunology [Nat Immunol] 2026 Jun 12. Date of Electronic Publication: 2026 Jun 12.
Publication Type: Journal Article
Journal Info: Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42286358
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent models.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Agrawal+N%22">Agrawal N</searchLink>; BioNTech SE, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Ates+LS%22">Ates LS</searchLink>; BioNTech SE, Mainz, Germany. louis.ates@biontech.de.<br /><searchLink fieldCode="AU" term="%22Schille+SA%22">Schille SA</searchLink>; BioNTech SE, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Chaturvedi+A%22">Chaturvedi A</searchLink>; BioNTech SE, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Vogt+J%22">Vogt J</searchLink>; BioNTech SE, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Vukovic+N%22">Vukovic N</searchLink>; BioNTech SE, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Dulberger+CL%22">Dulberger CL</searchLink>; BioNTech US, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Vogel+AB%22">Vogel AB</searchLink>; BioNTech SE, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Diekmann+J%22">Diekmann J</searchLink>; BioNTech SE, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Diken+M%22">Diken M</searchLink>; BioNTech SE, Mainz, Germany. mustafa.diken@biontech.de.; Translational Oncology at the University Medical Center of the Johannes Gutenberg-University Mainz (TRON), Mainz, Germany. mustafa.diken@biontech.de.<br /><searchLink fieldCode="AU" term="%22Şahin+U%22">Şahin U</searchLink>; BioNTech SE, Mainz, Germany.; Helmholtz Institute for Translational Oncology (HI-TRON), Mainz, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100941354%22">Nature immunology</searchLink> [Nat Immunol] 2026 Jun 12. <i>Date of Electronic Publication: </i>2026 Jun 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+America+Inc%22">Nature America Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100941354 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1529-2916 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215292908%22">15292908 </searchLink><i>NLM ISO Abbreviation: </i>Nat Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42286358
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41590-026-02545-z
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent models.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Agrawal N
      – PersonEntity:
          Name:
            NameFull: Ates LS
      – PersonEntity:
          Name:
            NameFull: Schille SA
      – PersonEntity:
          Name:
            NameFull: Chaturvedi A
      – PersonEntity:
          Name:
            NameFull: Vogt J
      – PersonEntity:
          Name:
            NameFull: Vukovic N
      – PersonEntity:
          Name:
            NameFull: Dulberger CL
      – PersonEntity:
          Name:
            NameFull: Vogel AB
      – PersonEntity:
          Name:
            NameFull: Diekmann J
      – PersonEntity:
          Name:
            NameFull: Diken M
      – PersonEntity:
          Name:
            NameFull: Şahin U
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 06
              Text: 2026 Jun 12
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1529-2916
          Titles:
            – TitleFull: Nature immunology
              Type: main
ResultId 1